01 Nov, 2013It’s Alive! 3D Cell Culture and Organoid Culture


Cell culture is the foundation of high throughput screening during drug development.  However, it is well known that there is a big and…

Read More

29 Oct, 2013Outsourcing is Changing Pharmaceutical Research – A Conversation with Kevin Lustig on The Empowered Patient


Kevin Lustig was invited by The Empowered Patient Radio Show after they heard Kevin at the Tech Coast Angels quick pitch competition.  Kevin…

Read More

24 Oct, 2013Key Factors in CRO Selection Part 1: Benefits of CRO use


Alternative strategies for approaching drug discovery and development have emerged in response to tightening budgets.  An appealing trend is the shift toward the…

Read More

17 Oct, 2013Strategic outsourcing of pharmaceutical R&D – Published in Chemistry Today


Dr Kevin Lustig talks about Strategic Outsourcing and bringing pharma and drug discovery into the information age in a recent publication in Chemistry…

Read More

15 Oct, 2013Government Shutdown Hinders Biomedical Research


Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and products…

Read More

08 Oct, 2013The Way to Patient-Centered Outcomes Research – Part 3


Patient perspective (patient-centered outcomes) is a crucial element in addressing health and illness issues for individuals on therapy. In the final article in…

Read More

01 Oct, 2013Patient-Reported Outcomes In Cancer Management – Part 2


A personalized medicine approach to clinical cancer therapy does not necessarily translate into a patient-centered approach as discussed in part 1 of this…

Read More

26 Sep, 2013Patient-Centered Outcomes in the Clinic – Part 1


In different regulatory and research settings, it is now being realized that the need to consider patient-centered outcomes is paramount. We invited Dr Sandeep…

Read More

10 Sep, 2013Healthy competition? Target diversity in drug development


Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug development targets remains…

Read More

13 Aug, 2013Assay Depot Announces Creation of Virtual Research Platform for Pfizer Scientists


Assay Depot  announced this morning, the launch of MXIS (Market Exchange for Innovative Services), a virtual outsourcing platform for Pfizer scientists. MXIS, an Assay…

Read More